1. Pecci A, Klersy C, Gresele P, Lee KJ, De Rocco D, Bozzi V, et al.
MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. Hum Mutat. 2014; 35:236–247.
Article
2. Balduini CL, Pecci A, Savoia A. Recent advances in the understanding and management of
MYH9-related inherited thrombocytopenias. Br J Haematol. 2011; 154:161–174.
Article
3. Thakral B, Rojanapremsuk T, Saluja K, Eldibany M. Misdiagnosed
MYH9 related inherited macrothrombocytopenia with an inadvertent splenectomy. Pathology. 2015; 47:377–379.
Article
4. Williamson DR, Albert M, Heels-Ansdell D, Arnold DM, Lauzier F, Zarychanski R, et al. Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest. 2013; 144:1207–1215.
Article
5. Savoia A, De Rocco D, Pecci A. MYH9 gene mutations associated with bleeding. Platelets. 2017; 28:312–315.
Article
6. Shiota M, Kunishima S, Hamabata T, Nakata M, Hata D. Early diagnosis improves the quality of life in MYH9 disorder. Pediatr Blood Cancer. 2012; 58:314–315.
7. Kim SJ, Lee S, Park HJ, Kang TH, Sagong B, Baek JI, et al. Genetic association of
MYH genes with hereditary hearing loss in Korea. Gene. 2016; 591:177–182.
Article
8. Oh T, Seo HJ, Lee KT, Kim HJ, Kim HJ, Lee JH, et al. MYH9 nephropathy. Kidney Res Clin Pract. 2015; 34:53–56.
9. Min SY, Ahn HJ, Park WS, Kim JW. Successful renal transplantation in
MYH9-related disorder with severe macrothrombocytopenia: first report in Korea. Transplant Proc. 2014; 46:654–656.
Article
10. Jang MJ, Park HJ, Chong SY, Huh JY, Kim IH, Jang JH, et al. A Trp33Arg mutation at exon 1 of the
MYH9 gene in a Korean patient with May-Hegglin anomaly. Yonsei Med J. 2012; 53:662–666.
Article
11. Han KH, Lee H, Kang HG, Moon KC, Lee JH, Park YS, et al. Renal manifestations of patients with
MYH9-related disorders. Pediatr Nephrol. 2011; 26:549–555.
Article
12. Kook H, Nam HS, Baek HJ, Kim YO, Eom GH, Kee HJ, et al. Clinical characteristics of autosomal dominant giant platelet syndromes and mutation analysis of
MYH9. Korean J Hematol. 2006; 41:16–27.
Article
13. Kunishima S, Matsushita T, Kojima T, Amemiya N, Choi YM, Hosaka N, et al. Identification of six novel
MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions. J Hum Genet. 2001; 46:722–729.
Article
14. Song KS, Choi JR, Song JW, Ha SK. A nonsence C5797T (R1933X) mutation of MYH9 gene in a family with May-Hegglin anomaly. Korean J Hematol. 2001; 36:253–256.
15. Noris P, Biino G, Pecci A, Civaschi E, Savoia A, Seri M, et al. Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. Blood. 2014; 124:e4–e10.
Article
16. Kunishima S, Matsushita T, Kojima T, Sako M, Kimura F, Jo EK, et al. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in
MYH9 disorders: association of subcellular localization with
MYH9 mutations. Lab Invest. 2003; 83:115–122.
Article
17. Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore). 2003; 82:203–215.
18. Shim YJ, Kim UH, Suh JK, Lee KS. Natural course of childhood chronic immune thrombocytopenia using the revised terminology and definitions of the international working group: a single center experience. Blood Res. 2014; 49:187–191.
Article
19. Pecci A, Panza E, Pujol-Moix N, Klersy C, Di Bari F, Bozzi V, et al. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of
MYH9-related disease. Hum Mutat. 2008; 29:409–417.
Article